A Systematic Review and Methodological Evaluation of Published Cost-Effectiveness Analyses of Aromatase Inhibitors versus Tamoxifen in Early Stage Breast Cancer

• Ava A. John-Baptiste ,

  * E-mail: ava.john-baptiste@wchospital.ca

  Affiliations Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada, Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada, Pharmacoeconomics Research Unit, Cancer Care Ontario, Toronto, Ontario, Canada, Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada, Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada

  ⨯
• Wei Wu,

  Affiliation Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada

  ⨯
• Paula Rochon,

  Affiliations Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada, Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada, Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Geoffrey M. Anderson,

  Affiliations Women’s College Research Institute, Women’s College Hospital, Toronto, Ontario, Canada, Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada, Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

  ⨯
• Chaim M. Bell

  Affiliations Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada, Institute of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada, Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯